TrialDiabetes, obesity & metabolism2015

One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension.

M C Riddle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.